Finch Therapeutics Group (FNCH) News Today $12.19 -0.01 (-0.08%) As of 09/19/2025 03:46 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock FNCH Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period FNCH - Finch Therapeutics Group Inc Price vs Fair Value - MorningstarJuly 4, 2025 | morningstar.comMFNCH Finch Therapeutics Group, Inc. - Seeking AlphaJune 24, 2025 | seekingalpha.comArquitos Capital's Largest Holdings For Q1 2025May 1, 2025 | seekingalpha.comArquitos Capital Management Q4 2024 CommentaryFebruary 5, 2025 | seekingalpha.comFinch Therapeutics Group, Inc.: Finch Announces Delisting from Nasdaq and SEC DeregistrationOctober 23, 2024 | finanznachrichten.deFinch Therapeutics announces Nasdaq delisting, SEC deregistrationOctober 22, 2024 | markets.businessinsider.comFinch Therapeutics Group to Delist from NasdaqOctober 22, 2024 | markets.businessinsider.comFinch Announces Delisting from Nasdaq and SEC DeregistrationOctober 21, 2024 | globenewswire.comFinch Therapeutics Gr (OTC:FNCH) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comFinch wins US jury trial against Ferring over fecal-transplant patentsAugust 10, 2024 | reuters.comFinch Therapeutics Group (Nasdaq:FNCH) HeadlineTrading was temporarily halted for "FNCH" at 09:04 AM with a stated reason of "LULD pause."...April 17, 2024 | marketbeat.comFinch Therapeutics Group (NASDAQ: FNCH)April 14, 2024 | fool.comJeffery A. Smisek Sells 6,642 Shares of Finch Therapeutics Group, Inc. (NASDAQ:FNCH) StockMarch 31, 2024 | insidertrades.comFNCH Stock Earnings: Finch Therapeutics Gr Reported Results for Q4 2023March 25, 2024 | investorplace.comFinch Therapeutics Group Inc (FNCH)March 7, 2024 | investing.comFinch Therapeutics Gr Stock (NASDAQ:FNCH), Short Interest ReportFebruary 22, 2024 | benzinga.comFinch Therapeutics Group (Nasdaq:FNCH) HeadlineTrading was temporarily halted for "FNCH" at 03:12 PM with a stated reason of "LULD pause." Trading set to resume at 03:12 PM. December 1, 2023 | marketbeat.comFinch Therapeutics Group (Nasdaq:FNCH) HeadlineTrading was temporarily halted for "FNCH" at 09:12 AM with a stated reason of "LULD pause."...December 1, 2023 | marketbeat.comFinch Therapeutics Group Inc FNCHNovember 5, 2023 | morningstar.comMFinch Therapeutics Group (Nasdaq:FNCH) HeadlineTrading was temporarily halted for "FNCH" at 09:10 AM with a stated reason of "LULD pause."...October 18, 2023 | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: Nuvation Bio (NUVB), Finch Therapeutics Group (FNCH)August 21, 2023 | markets.businessinsider.comFinch Therapeutics Group (Nasdaq:FNCH) HeadlineTrading was temporarily halted for "FNCH" at 03:06 PM with a stated reason of "LULD pause."...June 12, 2023 | marketbeat.comFinch Therapeutics Group (Nasdaq:FNCH) HeadlineTrading was temporarily halted for "FNCH" at 03:06 PM with a stated reason of "LULD pause."...June 12, 2023 | marketbeat.comFinch Therapeutics Group (Nasdaq:FNCH) HeadlineTrading was temporarily halted for "FNCH" at 02:06 PM with a stated reason of "LULD pause."...June 12, 2023 | marketbeat.comFinch Therapeutics Group, Inc.: Finch Announces Reverse Stock Split of Common StockJune 9, 2023 | finanznachrichten.deHC Wainwright & Co. Reiterates Finch Therapeutics Group (FNCH) Buy RecommendationMay 13, 2023 | msn.com8-K: Finch Therapeutics Group, Inc.May 12, 2023 | marketwatch.comFinch Therapeutics Group, Inc.: Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdatesMay 10, 2023 | finanznachrichten.deFinch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdatesMay 10, 2023 | finance.yahoo.comFinch Therapeutics Announces Executive Leadership TransitionsApril 25, 2023 | finance.yahoo.comFINCH THERAPEUTICS GROUP INCApril 22, 2023 | finanznachrichten.deFinch Therapeutics Announces Clinical Collaboration in Ulcerative Colitis with Brigham and Women’s Hospital and Updates to University of Minnesota License AgreementApril 18, 2023 | finance.yahoo.comFinch Therapeutics Group (FNCH) Gets a Buy from H.C. WainwrightApril 4, 2023 | markets.businessinsider.comFinch Therapeutics Group, Inc.: Finch Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdatesApril 3, 2023 | finanznachrichten.deLooking Into Finch Therapeutics Group's Return On Capital EmployedMarch 25, 2023 | msn.comFinch Therapeutics Group Full Year 2022 Earnings: Misses ExpectationsMarch 25, 2023 | finance.yahoo.comFinch Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdatesMarch 23, 2023 | finance.yahoo.comMicrobiome startup cuts 95% of remaining staff in 3rd layoff in 9 monthsJanuary 24, 2023 | finance.yahoo.comFinch Therapeutics Ending Phase 3 Study, Cutting Most of Workforce >FNCHJanuary 24, 2023 | marketwatch.comFinch Therapeutics Announces Decision to Discontinue Phase 3 Trial of CP101 and Focus on Realizing the Value of Its Intellectual Property Estate and Other AssetsJanuary 24, 2023 | finance.yahoo.comFinch Therapeutics Group (Nasdaq:FNCH) HeadlineTrading was temporarily halted for "FNCH" at 07:01 AM with a stated reason of "News pending."...January 24, 2023 | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: Kezar Life Sciences (KZR), RVL Pharmaceuticals (RVLP)November 11, 2022 | markets.businessinsider.comFinch Therapeutics Provides Corporate Updates and Reports Third Quarter 2022 Financial ResultsNovember 11, 2022 | finance.yahoo.comFinch Therapeutics to Present at the Jefferies London Healthcare Conference and Evercore ISI HealthCONx ConferenceNovember 9, 2022 | finance.yahoo.comFinch Therapeutics Presents PRISM-EXT Biomarker Data at ACG 2022 and Proceeds with Patient Dosing in Phase 3 Trial of CP101 in Recurrent C. Difficile InfectionOctober 24, 2022 | finance.yahoo.comFNCH Finch Therapeutics Group, Inc.October 1, 2022 | seekingalpha.comAfter Takeda ends collaboration, microbiome startup Finch Therapeutics cuts 50 jobsSeptember 1, 2022 | finance.yahoo.comFinch Therapeutics To Reduce Workforce - Quick FactsSeptember 1, 2022 | markets.businessinsider.comFinch Therapeutics Provides Business UpdateSeptember 1, 2022 | finance.yahoo.comFinch Therapeutics Group, Inc. (NASDAQ:FNCH) Short Interest Down 19.6% in AugustAugust 29, 2022 | marketbeat.com Get Finch Therapeutics Group News Delivered to You Automatically Sign up to receive the latest news and ratings for FNCH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FNCH Media Mentions By Week FNCH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FNCH News Sentiment▼0.000.79▲Average Medical News Sentiment FNCH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FNCH Articles This Week▼00▲FNCH Articles Average Week Get the Latest News and Ratings for FNCH and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Finch Therapeutics Group and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies IRD News BYSI News ASRT News CNTX News PMVP News UNCY News IGMS News RPTX News IZTC News ELYM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FNCH) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Finch Therapeutics Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Finch Therapeutics Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
